Firefly Neuroscience, Inc.
AIFF · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -78.3% | – | -100% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 38% | 100% | – | 100% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -9,557.4% | -518.9% | – | -11,928.1% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -9,685.2% | -522.7% | – | -13,690.6% |
| EPS Diluted | -1.6 | -0.33 | -0.48 | -0.56 |
| % Growth | -384.8% | 31.2% | 14.3% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |